Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma

Sanjay Ramakrishnan(Oxford BioMedica (United Kingdom)), Farhat Yasmin(Kettering General Hospital)

Oxford University Research Archive (ORA) (University of Oxford)

January 1, 2020

Cited by 59

Related Papers

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

|The Lancet Respiratory Medicine|2021|434

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

|The Lancet|2021|310

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide

|Thorax|2021|169

Survival analysis of patients on maintenance hemodialysis

|Indian Journal of Nephrology|2014|100

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial

|The Lancet Respiratory Medicine|2024|98